Organon (OGN) Interest Coverage Ratio (2021 - 2026)
Organon (OGN) recorded quarterly Interest Coverage Ratio of 2.12 in Q1 2026, up 21.99% quarter-over-quarter from 1.74 in Q4 2025, and up 9.84% on a YoY basis from 1.93 in Q1 2025.
Organon (OGN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Organon's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 2.12 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 9.84% year-over-year to 2.12; the TTM figure through Mar 2026 stood at 2.3 (down 11.07% YoY), while the FY2025 annual figure was 2.24, up 590.48% from the prior year.
- Interest Coverage Ratio was 2.12 for Q1 2026 at Organon, up from 1.74 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.26 in Q3 2024 to a low of 4.49 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 0.51 across 5 years, with a median of 1.23 in 2022.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio tumbled 113.04% in 2023, then soared 200.76% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 4.06 in 2022, then slipped by 10.58% to 4.49 in 2023, then soared by 148.61% to 2.18 in 2024, then dropped by 20.45% to 1.74 in 2025, then grew by 21.99% to 2.12 in 2026.
- The last three Interest Coverage Ratio figures came in at 2.12 (Q1 2026), 1.74 (Q4 2025), and 2.8 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,134,969.93 Bn | 92,134,964.97 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,027.45 Bn | 1,022.17 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 559.08 Bn | 537.03 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 394.75 Bn | 385.40 Bn | 10.78 Bn | - |
| 5 | Merck | 295.12 Bn | 289.47 Bn | 12.09 Bn | - |
| 6 | Amgen | 186.65 Bn | 174.61 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 159.22 Bn | 151.50 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 146.00 Bn | 133.23 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 113.22 Bn | 102.77 Bn | 8.07 Bn | - |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 2.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 |
| Dec 31, 2025 | 1.74 |
| Sep 30, 2025 | 2.80 |
| Jun 30, 2025 | 2.47 |
| Mar 31, 2025 | 1.93 |
| Dec 31, 2024 | 2.18 |
| Sep 30, 2024 | 3.26 |
| Jun 30, 2024 | 2.95 |
| Mar 31, 2024 | -3.27 |
| Dec 31, 2023 | -4.49 |
| Sep 30, 2023 | -3.97 |
| Jun 30, 2023 | -2.92 |
| Mar 31, 2023 | -2.61 |
| Dec 31, 2022 | -4.06 |
| Sep 30, 2022 | -2.49 |
| Jun 30, 2022 | -3.07 |
| Mar 31, 2022 | -1.23 |
| Dec 31, 2021 | -3.70 |
| Sep 30, 2021 | -2.24 |
| Jun 30, 2021 | -2.35 |